The VRI includes 150 researchers working on more than 40 international projects.


Constance Delaugerre Virologist

Constance Delaugerre completed her PharmD 1997 and has specialized in HIV clinical research. She defended her PhD thesis in 2003 on the “Molecular mechanisms of HIV drug resistance to antiretroviral drugs”. Associate Professor since 2007 in Clinical Virology in Saint Louis Hospital and Inserm U941, Paris Diderot University, France.
Research fields are (1) HIV viral reservoir dynamics in primary HIV infection and during lymhoma/stem cell transplantation and (2) antiretroviral pre-exposition prevention. She coordinates virological studies in ANRS and Vaccine Research Institute (VRI) trials: EASIER, OPTIMAL, REFLATE TB I & II, TREVE, LIGHT, DALIA-2 and IPERGAY.
She is the chairwoman of the Scientific and Medical Committee of Sidaction since 2012.